Kristian Humer

Insider Reports History

Entity
Individual
Location
C/O Viridian Therapeutics, Inc., 6200 Lookout Road, Boulder, CO
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristian Humer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Financial Officer Stock Option (right to buy) 120K $524K $4.37 Jan 22, 2025 Direct
Sensei Biotherapeutics, Inc. Director Common Stock 8.93K $7.59K $0.85 Jul 10, 2023 Direct
Viridian Therapeutics, Inc.\DE CFO and CBO Stock Option (Right to Buy) 108K Feb 8, 2023 Direct
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 19K Jun 11, 2024 Direct

Insider Reports Filed by Kristian Humer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Jan 22, 2025 1 $524K 4 Jan 24, 2025 Chief Financial Officer
SNSE Sensei Biotherapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
FHTX Foghorn Therapeutics Inc. Apr 16, 2024 1 $1.66M 4 Apr 17, 2024 Chief Financial Officer
FHTX Foghorn Therapeutics Inc. Apr 16, 2024 0 $0 3 Apr 17, 2024 Chief Financial Officer
SNSE Sensei Biotherapeutics, Inc. Jul 10, 2023 2 $0 4 Jul 12, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Feb 8, 2023 1 $0 4 Feb 10, 2023 CFO and CBO
SNSE Sensei Biotherapeutics, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
VRDN Viridian Therapeutics, Inc.\DE Feb 2, 2022 1 $0 4 Feb 3, 2022 CFO and CBO
VRDN Viridian Therapeutics, Inc.\DE Dec 31, 2021 1 $0 4 Jan 3, 2022 CFO and CBO
SNSE Sensei Biotherapeutics, Inc. Jul 30, 2021 1 $0 4 Aug 2, 2021 Director
SNSE Sensei Biotherapeutics, Inc. Jul 30, 2021 0 $0 3 Aug 2, 2021 Director
VRDN Viridian Therapeutics, Inc.\DE Jul 26, 2021 1 $0 4 Jul 27, 2021 CFO and CBO
VRDN Viridian Therapeutics, Inc.\DE Jul 26, 2021 0 $0 3 Jul 27, 2021 CFO and CBO
VRDN Viridian Therapeutics, Inc.\DE Jul 26, 2021 0 $0 3 Jul 27, 2021 CFO and CBO